We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
Cap. Flow
+$1.55B
Cap. Flow %
8.12%
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180

Top Buys

Rank Stock Value
1
ELAN icon
Elanco Animal Health
ELAN
+$89.1M
2
WEX icon
WEX
WEX
+$78.4M
3
BLK icon
Blackrock
BLK
+$73.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$71.9M
5
OMF icon
OneMain Financial
OMF
+$45.3M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$63.6M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$56.6M
3
AEM icon
Agnico Eagle Mines
AEM
+$55.1M
4
DFS
Discover Financial Services
DFS
+$36M
5
ORBC
ORBCOMM, Inc.
ORBC
+$27.5M

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 14.65%
3 Healthcare 12.11%
4 Consumer Discretionary 7.54%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRC icon
3476
Ameresco
AMRC
$1.36B
$1K ﹤0.01%
30
– –
AMWL icon
3477
American Well
AMWL
$230M
$1K ﹤0.01%
8
-100
-93% -$21.7K
CVSA
3478
Covista Inc
CVSA
$4.8B
$1K ﹤0.01%
+35
New +$1.3K
AVNS
3479
DELISTED
Avanos Medical
AVNS
$1K ﹤0.01%
63
+3
+5% +$102
DCH
3480
Dauch Corp
DCH
$1.51B
$1K ﹤0.01%
159
– –
BBHY icon
3481
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$618M
$1K ﹤0.01%
20
– –
BEKE icon
3482
KE Holdings
BEKE
$18.8B
$1K ﹤0.01%
71
+61
+610% +$1.49K
BH icon
3483
Biglari Holdings Class B
BH
$1.21B
$1K ﹤0.01%
+10
New +$1.68K
BNO icon
3484
United States Brent Oil Fund
BNO
$727M
$1K ﹤0.01%
50
– –
BNTC icon
3485
Benitec Biopharma
BNTC
$468M
$1K ﹤0.01%
18
– –
BUSE icon
3486
First Busey Corp
BUSE
$2.56B
$1K ﹤0.01%
81
– –
BXC icon
3487
BlueLinx
BXC
$706M
$1K ﹤0.01%
+33
New +$1.66K
CACC icon
3488
Credit Acceptance
CACC
$6.08B
$1K ﹤0.01%
3
– –
CAR icon
3489
Avis
CAR
$5.02B
$1K ﹤0.01%
16
– –
CCRD
3490
DELISTED
CoreCard
CCRD
$1K ﹤0.01%
25
– –
CIVB icon
3491
Civista Bancshares
CIVB
$589M
$1K ﹤0.01%
+70
New +$1.61K
CLDX icon
3492
Celldex Therapeutics
CLDX
$3.28B
$1K ﹤0.01%
+34
New +$1.59K
CLM icon
3493
Cornerstone Strategic Value Fund
CLM
$2.25B
$1K ﹤0.01%
102
-203
-67% -$2.48K
CMP icon
3494
Compass Minerals
CMP
$1.15B
$1K ﹤0.01%
31
– –
CNX icon
3495
CNX Resources
CNX
$5.2B
$1K ﹤0.01%
146
– –
CTRN icon
3496
Citi Trends
CTRN
$605M
$1K ﹤0.01%
14
– –
CVEO icon
3497
Civeo
CVEO
$318M
$1K ﹤0.01%
47
– –
DAKT icon
3498
Daktronics
DAKT
$1.04B
$1K ﹤0.01%
+193
New +$1.15K
DCBO
3499
Docebo
DCBO
$566M
$1K ﹤0.01%
+26
New +$1.91K
DDS icon
3500
Dillards
DDS
$9.56B
$1K ﹤0.01%
+11
New +$2.09K
138 139
140
141 142

Similar funds

Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Rockefeller Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.

  • Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
  • Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
  • Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
  • Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
  • Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
  • Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
  • Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.

Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.